Come up with a name for your new list and we'll add to it:
Insera Therapeutics raised a round of funding on January 19, 2010. Investors include
National Science Foundation.
Insera Therapeutics is a company that received a SBIR Phase I grant for a project entitled: Technology development and pre-clinical testing of a novel minimally invasive catheter-based blood clot-retr…